Investors Give, Then Take Away, in Meihua’s New York Trading Debut

Shares of disposable medical products maker soar 30% on first trading day, only to fall even more the next day, as it becomes just the second Chinese listing in the U.S. since last summer Key takeaways: Shares of disposable medical products maker Meihua rose 30% on their first trading day in New York, but fell by a similar amount the next day and now trade below their IPO price The listing is only the second by a Chinese company in the U.S. since a regulatory-related pause last summer, indicating such…

Read More »

PW Medtech’s Buying Spree: Diversification or Insider Story?

The manufacturer of medical infusion devices has recently made two interesting acquisitions Key takeaways: After buying a related peer in November, PW Medtech acquired a human tissue regeneration and repair product developer last week at a high premium The company’s performance has been affected by the pandemic, and it may hope the new acquisitions will lower such risk through diversification By Jony Ho Medical device maker PW Medtech Group Ltd. (1358.HK) has struggled lately, dragged down by pandemic-related disruptions. Perhaps seeking to lower that risk, the company has made two…

Read More »

FAST NEWS: PW Medtech Shares Jump on Acquisition

The latest: Medical infusion products maker PW Medtech Group Ltd. (1358.HK) announced it will acquire 51% of Sichuan Ruijian Medical Technology Co. Ltd., another medical device maker, for a cash consideration of $99.46 million. Looking up: Sichuan Ruijian develops, manufactures and sells blood purification equipment. PW Medtech will expand its product portfolio through the acquisition and take a step into the blood purification market. Take Note: Lepu Medical will remain a shareholder of Sichuan Ruijian with 18% of the company. Lepu Medical is controlled by Pu Zhongjie, husband of PW…

Read More »